CHICAGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (Innovator) today announced the listing of the Innovator IBD® ETF Leaders ETF (LDRS) on the NYSE Arca. LDRS is an ETF of ETFs that seeks to outperform the broader equity and fixed income markets.
The Innovator IBD ETF Leaders ETF is designed to track the performance of the IBD Leaders ETF Index, before fees and expenses. Developed and managed by Investor’s Business Daily® (IBD), the Index is rules-based using proprietary relative strength analysis and other objective performance ratings to select ETFs across various asset classes and geographies that are demonstrating market-leading relative strength.
“Investors’ desire for wealth management solutions that are easily accessed, rules-based, and low-cost has driven the rapid growth of automated, robo-constructed ETF managed portfolios. By delivering a dynamic global asset allocated ETF strategy that adapts to changing markets within an ETF wrapper, we can achieve better tax-efficiency for investors. The Innovator IBD® ETF Leaders ETF is a single ticket solution that provides structural alpha that cannot be replicated by robos or a traditional wealth management approach,” said Bruce Bond, Chief Executive Officer of Innovator Capital Management.
“LDRS provides a unique approach to constructing a tactical portfolio of ETFs using IBD’s time tested research to identify top performing ETFs. IBD’s independent analysis of the investment universe ensures a comprehensive evaluation of all opportunities without any ETF issuer bias,” added Graham Day, Innovator’s Vice President of Product & Research.
The Innovator IBD Leaders ETF Index selection universe is composed of all U.S.-listed ETFs registered under the 1940 Investment Company Act, and narrowed by excluding ETFs with low trading volume, and returns below the S&P 500 Index over the previous three months. The remaining ETFs are ranked according IBD’s relative price strength rating methodology with the highest scoring ETFs included and equally weighted within the Index. Under normal circumstances, the Index will be reconstituted and rebalanced on the last trading day of each month.
The Innovator IBD® ETF Leaders ETF expands Innovator’s suite based upon Investor’s Business Daily’s powerful, time tested investment methodology. The Innovator IBD® 50 ETF (NYSE Arca:FFTY), launched in April 2015, was recently ranked by Morningstar as the Best Performing ETF over a 1-year period in the Mid-Cap Growth category from November 30, 2016 to November 30, 2017. The rank is measured by the fund’s NAV trailing total returns based on 23 ETFs in the mid-cap growth category.
About Investor’s Business Daily
Investor’s Business Daily is a leading financial news and research organization recognized for providing stock screens, comparative performance ratings, and unique commentary helping investors zero in on top performing growth stocks and ETFs. The company takes a data-first approach to investing, educating investors about how to invest successfully using tested methods and sound research. IBD has honed its approach over the last 50 years to help investors make smarter decisions and offers individual and professional investors a comprehensive lineup of print and online products, all based on a powerful investing system that has dramatically outperformed the S&P 500. IBD® was founded April 9, 1984 by William J. O'Neil, who also originated CAN SLIM.
About Innovator Capital Management, LLC
Innovator Capital Management, LLC is an SEC registered investment advisor (RIA) based in Wheaton, IL. Formed in 2014, the firm is currently headed by ETF visionaries Bruce Bond and John Southard, founders of one of the largest ETF providers in the world. Innovation is our hallmark and acts as a guide to our company principles. Innovator is committed to helping investors better control their financial outcomes by providing investment opportunities they never considered or thought possible.
+1 (303) 415-2290
©2017 Morningstar, Inc. All Rights Reserved. The information herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Investing involves risks. Principal loss is possible. ETFs face numerous market trading risks, including the potential lack of an active market for Fund shares, losses from trading in secondary markets, periods of high volatility and disruption in the creation/redemption process of the Fund. Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. ETFs are bought and sold at market price and not individually redeemed from the fund. Brokerage commissions will reduce returns. It is not possible to invest directly in an index.
The “IBD®” mark and logo have been licensed to the Adviser by Investor’s Business Daily, Inc. (IBD) for use in connection with the Fund under certain circumstances. The Fund is not sponsored, endorsed or sold by IBD. IBD makes no representation regarding the advisability of investing in the Fund. Investor’s Business Daily® mark and associated logos are used with permission by IBD.
The Fund’s investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and may be obtained at innovatoretfs.com. Read it carefully before investing.
Innovator ETFs are distributed by Foreside Fund Services, LLC.
Copyright © 2017 Innovator Capital Management, LLC.